Research Information System
VIII.Middle East International Conference On Contemporary Scientific Studies, Ankara, Turkey, 7 - 08 January 2023, pp.323-334, (Full Text)
Cervical cancer continues to be an important cause of morbidity and mortality in women's
health. However, with the development of effective vaccines, early diagnosis and effective
treatment, it is possible to prevent and eliminate cervical cancer. Success in the management of
cervical cancer has been shown to be effective in achieving goals not only in high-income
countries but worldwide when adequate strategies are established. Penile precancerous and
cancerous diseases, vulvar, vaginal, oropharyngeal, anal, cervical diseases as well as anogenital
warts that are caused by vaccine-specific HPV types are preventable through Human Papilloma
Virus (HPV) vaccines. High-quality clinical trials and population-based studies have proved the
efficacy and effectiveness of HPV vaccines, that resulted to the stronger herd immunity and
reduction of HPV-related diseases respectively. The efficacy of the vaccine decreases after
exposure to HPV disease therefore the vaccine should be administered to prepubertal children
before the reproductive period, since it is more immunogenic under 15 years of age. Prevention
of HPV transmission rapidly reduces the cancer burden. Cervical cancer elimination is on the
global agenda and is evidence to the great medical improvements in recent years. cervical
cancer is prevented now by screening programs and HPV vaccine and also effective
chemotherapy, radiotherapy and surgery. However, there were more than 500K new cases in
2018 with approximately 300K deaths worldwide. Despite problems in supply, cost, delivery,
HPV vaccine needs to be made available to everyone who needs it. Health systems,
governments, non-governmental organizations, the private sector and academics have great
responsibilities in overcoming the negative effects of cervical cancer on women's health.